John Horan

Dana-Farber Cancer Institute — United States

Medicine · Health Sciences

38h-index4.9kcitations175works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(79), Acute Myeloid Leukemia Research(43), Acute Lymphoblastic Leukemia research(39), Hemoglobinopathies and Related Disorders(36), Immune Cell Function and Interaction(23)

Publications175 total

<scp>RBC</scp> Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A <scp>STAR</scp> Registry Report
American Journal of Hematology·2026
Children and adolescents with sickle cell disease demonstrate improved health-related quality of life and low decisional regret after hematopoietic cell transplantation: A sickle cell transplant advocacy and research alliance (STAR) study
Blood·2025Open Access
T cell receptor costimulation blockade effectively prevents acute graft versus host disease without reducing the size or diversity of the T cell immune repertoire
Blood·2025
Discovery of the transcription factor ZNF683/hobit as a central regulator of pathogenic T cell proliferation in acute gvhd
Blood·2025Open Access
Provider practices and preparedness for gene therapy in pediatric sickle cell disease: A national survey of pediatric hematologists
Blood·2025Open Access
Erratum: Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group
Journal of Clinical Oncology·2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group
Journal of Clinical Oncology·2025· 3 citedOpen Access
Favorable Long-Term Outcomes of Umbilical Cord Blood Transplantation in Primary Hemophagocytic Lymphohistiocytosis: A 20-Year Institutional Review
Transplantation and Cellular Therapy·2025
Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)
Blood·2024Open Access
A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO - a Report from the Children's Oncology Group
Blood·2024· 3 citedOpen Access
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation
Blood·2024· 21 citedOpen Access
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities
Transplantation and Cellular Therapy·2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Bone Marrow Transplantation·2024· 1 citedOpen Access
Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study
Transplantation and Cellular Therapy·2024
Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study
Blood·2023· 1 cited
Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study
Blood·2023Open Access
Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Blood·2023· 1 cited
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation
Clinical Case Reports·2023· 2 citedOpen Access
TREATMENT OF RECURRENT PEDIATRIC MYELODYSPLASTIC SYNDROME POST HEMATOPOIETIC STEM CELL TRANSPLANTATION
2023Open Access
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Research Square (Research Square)·2023Open Access
page 1 of 9Next →

Frequent Co-authors

Leslie S. Kean(9), Gregory A. Hale(8), Mary Eapen(7), Muna Qayed(6), Michael A. Pulsipher(6), Kirk R. Schultz(6), Edmund K. Waller(6), Amelia Langston(6), Robert Peter Gale(6), Mitchell S. Cairo(6), William G. Woods(6), Benjamin Watkins(5), Stephen R. Spellman(5), Haydar Frangoul(5), Mark C. Walters(5), Todd A. Alonzo(5), Paul A. Carpenter(5), Yvonne Suessmuth(4), Roger Giller(4), John E. Levine(4)